Psychiatrist/Psychiatric Mental Health Nurse Practitioner
Neuronetics
Psychiatrist/Psychiatric Mental Health Nurse Practitioner
Neuronetics
Non-invasive TMS device for depression
About Neuronetics
Neuronetics is a medical technology company focused on designing, developing, and marketing products that improve quality of life for patients suffering from psychiatric disorders. Neuronetics’ NeuroStar® Advanced Therapy is today’s leading TMS (transcranial magnetic stimulation) technology and was the first TMS system designed for clinical use in the treatment of people with major depressive disorder (MDD).
Each day, we remain committed to our mission and values. We have passion for purpose and work with integrity, fearlessness, respect, and as a unified team. If you are driven, take initiative, want to enjoy what you do, and positivity is your middle name, we are interested in hearing from you!
Greenbrook is a leading provider of Transcranial Magnetic Stimulation (TMS) therapy, which administers local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Additionally, Greenbrook now offers the only FDA-approved ketamine-based psychedelic treatment for depression. Since inception, Greenbrook has provided more than 1.3 MILLION TMS treatments to over 40,000 patients struggling with depression.
Over 16 million Americans are affected by depression. Greenbrook TMS is changing the way that depression is treated, and YOU can be part of making a positive difference in the lives of patients by joining our amazing team!
To learn more about ourWHY,click here:https://youtu.be/yrr-wlFftT0
For patient testimonies onHOWwe are transforming lives for the better, click here:https://www.greenbrooktms.com/patient-stories
To access provider information, click here:https://www.greenbrookproviders.com
GBSP25
[]
Non-invasive TMS device for depression
Neuronetics makes non-invasive neurostimulation devices for psychiatric disorders, led by the NeuroStar Advanced Therapy system that uses transcranial magnetic stimulation to treat mood disorders. Treatments are outpatient, short sessions with no anesthesia, targeting mood-regulation brain areas. Revenue comes from selling or leasing devices and selling single-use treatment components; after acquiring Greenbrook TMS, they also operate their own network of treatment centers. Their goal is to expand neuromodulation use, grow the installed base, and scale both device sales and clinics to help more patients.
Explore more opportunities at Neuronetics